Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Stoehr

Showing results (51-60 of 195) with videos related to

Pageof 20
Sort By:
Virchows Archiv : an International Journal of Pathology|August 14, 2021
Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the footAbbas Agaimy, Norbert Meidenbauer, William R Sukov, et al.
Journal of Clinical Pathology|September 5, 2006
Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phaseEllen C Obermann, Philip Went, Alexandar Tzankov, et al.
European Urology|October 24, 2008
Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parametersElke Eltze, Peter J Wild, Christian Wülfing, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 5, 2009
Regulation of uptake of 18F-FDG by a follicular human thyroid cancer cell line with mutation-activated K-rasOlaf Prante, Simone Maschauer, Valerie Fremont, et al.
Human Pathology|October 24, 2007
Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancerMatthias Woenckhaus, Johannes Merk, Robert Stoehr, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2009
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancerBarbara Seliger, Robert Stoehr, Diana Handke, et al.
Disease Markers|January 10, 2020
Molecular Composition of Genomic <i>TMPRSS2-ERG</i> Rearrangements in Prostate CancerManuela Krumbholz, Abbas Agaimy, Robert Stoehr, et al.
Human Pathology|January 24, 2006
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analysesStefan Denzinger, Kristin Mohren, Ruth Knuechel, et al.
Oncology Reports|December 5, 2003
No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tractRobert Stoehr, Anke Brinkmann, Thomas Filbeck, et al.
The American Journal of Surgical Pathology|May 9, 2018
Intraductal Papillary Mucinous Neoplasms of Minor Salivary Glands With AKT1 p.Glu17Lys MutationAbbas Agaimy, Sarina K Mueller, Klaus Bumm, et al.
Pageof 20

Showing results (51-60 of 195) with videos related to

Sort By:
Pageof 20
Virchows Archiv : an International Journal of Pathology|August 14, 2021
Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the footAbbas Agaimy, Norbert Meidenbauer, William R Sukov, et al.
Journal of Clinical Pathology|September 5, 2006
Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phaseEllen C Obermann, Philip Went, Alexandar Tzankov, et al.
European Urology|October 24, 2008
Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parametersElke Eltze, Peter J Wild, Christian Wülfing, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 5, 2009
Regulation of uptake of 18F-FDG by a follicular human thyroid cancer cell line with mutation-activated K-rasOlaf Prante, Simone Maschauer, Valerie Fremont, et al.
Human Pathology|October 24, 2007
Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancerMatthias Woenckhaus, Johannes Merk, Robert Stoehr, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2009
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancerBarbara Seliger, Robert Stoehr, Diana Handke, et al.
Disease Markers|January 10, 2020
Molecular Composition of Genomic <i>TMPRSS2-ERG</i> Rearrangements in Prostate CancerManuela Krumbholz, Abbas Agaimy, Robert Stoehr, et al.
Human Pathology|January 24, 2006
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analysesStefan Denzinger, Kristin Mohren, Ruth Knuechel, et al.
Oncology Reports|December 5, 2003
No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tractRobert Stoehr, Anke Brinkmann, Thomas Filbeck, et al.
The American Journal of Surgical Pathology|May 9, 2018
Intraductal Papillary Mucinous Neoplasms of Minor Salivary Glands With AKT1 p.Glu17Lys MutationAbbas Agaimy, Sarina K Mueller, Klaus Bumm, et al.
Pageof 20